Post-approval studies (Phase 4)Study completedNCT01421719
What this trial is testing
Safety and Efficacy of botulinumA Toxin (BotoxA) for Treatment of Neurogenic Bladder of Parkinson's Disease
Who this might be right for
Parkinson's DiseaseNeurogenic BladderUrinary Incontinence+1 more
Stanford University 20